|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash stock-based expense | |||||
| (Loss) gain on extinguishment of debt | |||||
| Impairments of goodwill and intangible assets | |||||
| Gain on sale of assets | |||||
| Deferred income taxes | |||||
| Distributions from investments | |||||
| Equity in (earnings) losses from investments | |||||
| Net gains on investment securities | |||||
| Net (gains) losses on investment securities | |||||
| Equity in (earnings) losses from real estate ventures | |||||
| Distributions from real estate ventures | |||||
| Non-cash interest expense | |||||
| Non-cash lease expense | |||||
| Non-cash portion of restructuring charges | |||||
| Provision for credit losses | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Receivables | |||||
| Inventories | |||||
| Accounts payable and accrued liabilities | |||||
| Payments due under the Master Settlement Agreement | |||||
| Investments in real estate, net | |||||
| Litigation accruals | |||||
| Other assets and liabilities, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Sale of investment securities | |||||
| Maturities of investment securities | |||||
| Purchase of investment securities | |||||
| Proceeds from sale or liquidation of long-term investments | |||||
| Purchase of long-term investments | |||||
| (Increase) decrease in restricted assets | |||||
| Investments in real estate ventures | |||||
| Distributions from investments in real estate ventures | |||||
| Cash acquired in purchase of subsidiaries | |||||
| Proceeds from sale of fixed assets | |||||
| Capital expenditures | |||||
| Increase in cash surrender value of life insurance policies | |||||
| Purchase of subsidiaries | |||||
| Pay downs of investment securities | |||||
| Investments in real estate, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of debt | |||||
| Repayments of debt | |||||
| Deferred financing costs | |||||
| Borrowings under revolver | |||||
| Repayments on revolver | |||||
| Dividends and distributions on common stock | |||||
| Distributions to non-controlling interest | |||||
| Contributions from non-controlling interest | |||||
| Proceeds from the issuance of common stock | |||||
| Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting and exercise of stock options | |||||
| Cash transferred to Douglas Elliman Inc. at the Distribution | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
Loading...